IBRX-042 In Participants With HPV-Associated Tumors
NCT05976828
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
HPV-Related Carcinoma
Interventions
DRUG:
IBRX-042
Sponsor
ImmunityBio, Inc.